Cross-Researcher Connection Map

63 connections mapped across 30 reviewed prize entrants.

Summary

Type	Count
Contradicts	3
Converges	26
Extends	25
Parallel	5
Supports	4

Strength	Count
Moderate	29
Strong	31
Weak	3

Converges (26)

Ralph Nixon ↔ Gunnar Gouras (strong)

Both identify endosomal-lysosomal dysfunction as the core pathogenic hub. Nixon's vATPase/lysosomal de-acidification model and Gouras's intraneuronal Abeta accumulation in synaptic endosomes converge on the same compartment, with Gouras explicitly citing PANTHOS as the terminal morphology Nixon described.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Estela Area-Gomez (strong)

Both identify C99/APP-betaCTF accumulation as a direct inhibitor of vATPase. Area-Gomez adds the lipid disorder dimension, showing C99 acts as a cholesterol sensor whose accumulation causes dual toxicity at MAM (lipid dysregulation) and lysosomes (vATPase inhibition).

Shared nodes: Endosomal Nexus

Pamela Maher ↔ Ashley Bush (strong)

Both place lipid peroxidation and ferroptotic cell death at the center of AD pathogenesis. Maher focuses on glutathione/GPX4 depletion and 4-HNE toxicity, while Bush emphasizes iron accumulation and Fenton chemistry as the driver. Both converge on unchecked lipid peroxide accumulation as the terminal event.

Shared nodes: Endosomal Nexus

Pamela Maher ↔ Russell Swerdlow (moderate)

Both identify mitochondrial dysfunction as a central pathogenic mechanism. Maher's ROS feed-forward loop from failed mitophagy and Swerdlow's age-dependent mitochondrial decline converge on the same bioenergetic crisis that starves vATPase of ATP.

Shared nodes: Endosomal Nexus

Pamela Maher ↔ Jeevan Pradhan (moderate)

Both invoke the oxytosis/ferroptosis pathway as a central AD mechanism. Pradhan explicitly integrates Maher's glutathione depletion and ROS accumulation into his multi-factor 'decryption model' of AD, validating the oxytosis/ferroptosis framework within a systems biology context.

Shared nodes: Endosomal Nexus

Bernd Moosmann ↔ Ari Rappoport (strong)

Both reframe Abeta and tau as compensatory responses rather than primary causes. Moosmann sees Abeta as a glutamatergic sensitizer compensating for NMDA hypofunction; Rappoport sees it as a double-edged plasticity signal. Both converge on ApoE4-mediated receptor trapping as the upstream trigger.

Shared nodes: Compensatory Paradigm Nexus, APOE4 Hub

Bernd Moosmann ↔ Zaven Khachaturian (strong)

Both place calcium signaling failure upstream of lysosomal dysfunction. Moosmann's NMDA hypofunction deprives neurons of calcium needed for vATPase assembly; Khachaturian's calcium dysregulation activates calpain-mediated vATPase destruction. Different calcium perturbations converge on the same lysosomal outcome.

Shared nodes: Endosomal Nexus

Gunnar Gouras ↔ Daniel Michaelson (strong)

Both identify ApoE4-mediated endosomal trapping as a key pathogenic mechanism. Gouras shows ApoE4 traps LRP1 and GluA1 in endosomes causing recycling block; Michaelson shows ApoE4 itself becomes trapped at its isoelectric point, starving endolysosomal membranes of lipids.

Shared nodes: Endosomal Nexus, APOE4 Hub

Gunnar Gouras ↔ Ari Rappoport (strong)

Both describe ApoE4-driven endosomal traffic jams as central to AD. Gouras focuses on receptor trapping and Abeta accumulation in enlarged endosomes; Rappoport frames it as pH-dependent isoelectric precipitation of ApoE4 in early endosomes. Both converge on NHE6/vATPase-mediated acidification failure.

Shared nodes: Endosomal Nexus, APOE4 Hub

Gunnar Gouras ↔ Estela Area-Gomez (strong)

Both identify intraneuronal C99/betaCTF accumulation as pathogenic. Gouras focuses on Abeta42 generated from synaptic endosomal processing; Area-Gomez shows C99 accumulation creates dual toxicity via MAM lipid dysregulation and direct vATPase inhibition at lysosomes.

Shared nodes: Endosomal Nexus

Ruth Itzhaki ↔ Richelle Cutler (strong)

Both identify herpesviruses as primary environmental triggers for sporadic AD. Itzhaki focuses on HSV1 latency-reactivation in APOE4 carriers; Cutler extends to multiple herpesviruses (HSV-1/2, VZV, EBV, HCMV) operating through a viral-adrenergic nexus via the Locus Coeruleus.

Shared nodes: Endosomal Nexus

Stephen Dominy ↔ Annalise Barron (strong)

Both implicate P. gingivalis as a key AD pathogen. Dominy focuses on gingipain-mediated sabotage of autophagy-lysosomal function; Barron shows gingipains also degrade LL-37, breaking the innate immune checkpoint that normally prevents Abeta aggregation.

Shared nodes: Neuroimmune Interface

Estela Area-Gomez ↔ Ari Rappoport (strong)

Both identify cholesterol/lipid dysregulation as the fundamental driver of AD. Area-Gomez shows C99 signals false cholesterol deficiency driving MAM hyperactivation; Rappoport shows astrocyte-to-neuron cholesterol shuttle failure destabilizes lipid rafts. Both converge on lipid raft disruption impairing vATPase.

Shared nodes: Endosomal Nexus, APOE4 Hub

Estela Area-Gomez ↔ Daniel Michaelson (strong)

Both frame AD as a lipid disorder centered on ApoE4. Michaelson shows ApoE4 hypolipidation starves membranes; Area-Gomez shows C99 accumulation creates false cholesterol deficiency signals. Both converge on endolysosomal membrane lipid composition failure causing vATPase disassembly.

Shared nodes: Endosomal Nexus, APOE4 Hub

Bess Frost ↔ Erwin Roggen (moderate)

Both place tau-driven pathology and epigenetic dysregulation at the center of neurodegeneration. Frost shows tau-induced chromatin restructuring and LINE-1 reactivation; Roggen identifies tau hyperphosphorylation via GSK3beta/Cdk5 as a key step in his Adverse Outcome Pathway, with both implicating epigenetic alterations.

Shared nodes: Transcriptional-Epigenetic Dysregulation Node

Zhen Huang ↔ Donald Weaver (strong)

Both reclassify Abeta as an innate immune molecule rather than a simple toxic byproduct. Huang frames it as an antimicrobial peptide mediating synaptic competition; Weaver classifies it as an innate immune cytokine that attacks neurons via electrophysiological identity error. Both see pathology arising from dysregulated immune function.

Shared nodes: Neuroimmune Interface, Compensatory Paradigm Nexus

Michal Schwartz ↔ Charles Greenblatt (strong)

Both propose immune restoration as the therapeutic strategy. Schwartz uses PD-L1 checkpoint blockade to rejuvenate exhausted T cells and recruit MDMs; Greenblatt uses BCG to induce trained immunity and LL-37 defense. Both converge on peripheral immune cell recruitment to clear aggregates microglia cannot handle.

Shared nodes: Neuroimmune Interface

Brenda Aske ↔ Carina Clawson (strong)

Both identify lipid dysregulation as the initiating event driving immune-metabolic failure. Aske focuses on cholesterol-laden LDAM microglia and the glial relay; Clawson emphasizes ceramide dysregulation and sphingolipid-mediated BACE1 stabilization. Both describe positive feedback loops between lipid and protein pathology.

Shared nodes: Endosomal Nexus, Neuroimmune Interface

Brenda Aske ↔ Estela Area-Gomez (moderate)

Both frame AD as fundamentally a lipid metabolic disorder. Area-Gomez focuses on neuronal C99/cholesterol sensor dysfunction at MAMs; Aske focuses on glial lipid overload causing LDAM formation. Both converge on cholesterol/lipid raft disruption driving lysosomal failure, but in different cell types.

Shared nodes: Endosomal Nexus, APOE4 Hub

Carina Clawson ↔ Estela Area-Gomez (moderate)

Both identify ceramide/sphingolipid dysregulation as central to AD. Clawson shows ceramides stabilize BACE1 and activate GSK-3beta via PP2A; Area-Gomez shows sphingomyelin and cholesterol ester imbalance from MAM hyperactivation. Both link lipid dysregulation to BACE1-mediated amyloidogenic processing.

Shared nodes: Endosomal Nexus

Varghese John ↔ Daniel Michaelson (strong)

Both identify ApoE4-mediated transcriptional/post-transcriptional mechanisms destroying vATPase. John shows ApoE4 suppresses SIRT1 leading to ATP6V1A mRNA degradation via IGF2BP2/XRN2; Michaelson shows ApoE4 hypolipidation destabilizes vATPase V1/V0 domains. Two complementary paths from ApoE4 to vATPase failure.

Shared nodes: APOE4 Hub, Endosomal Nexus

Varghese John ↔ Li-Huei Tsai (moderate)

Both focus on gamma oscillation enhancement as a therapeutic approach, with John providing the molecular pharmacology (DDL-218, Tropisetron, F03 compounds) and Tsai providing the biophysical entrainment approach (GENUS 40Hz stimulation). Both converge on vATPase restoration as the critical therapeutic target.

Shared nodes: Endosomal Nexus

Erwin Roggen ↔ Paul Cox (moderate)

Both propose environmental exposures as the primary trigger for sporadic AD. Roggen identifies 27 neurotoxicants (pesticides, metals) converging on mitochondrial dysfunction; Cox identifies a single cyanobacterial toxin (BMAA) misincorporated into proteins. Both explain the sporadic nature of AD through cumulative environmental insults.

Shared nodes: Endosomal Nexus

Charles Greenblatt ↔ Annalise Barron (strong)

Both identify LL-37 cathelicidin as a key anti-amyloid defense molecule. Greenblatt shows BCG vaccination upregulates LL-37 via Vitamin D pathways; Barron demonstrates LL-37 acts as a chaperone preventing Abeta fibrillation. Together they provide both the mechanism and the therapeutic for LL-37-based intervention.

Shared nodes: Neuroimmune Interface

Brian Head ↔ Ari Rappoport (strong)

Both identify cholesterol transport failure as fundamental to AD and converge on lipid raft stabilization as the therapeutic target. Rappoport describes the astrocyte-to-neuron cholesterol shuttle failure; Head's SynCav1 gene therapy restores the membrane lipid raft scaffolding that this failure destroys.

Shared nodes: Endosomal Nexus, APOE4 Hub

Ari Rappoport ↔ Carina Clawson (moderate)

Both identify lipid metabolism failure as the initiating event. Rappoport focuses on cholesterol deficiency and lipid raft destabilization; Clawson focuses on ceramide accumulation and sphingolipid dysregulation. Both lipid perturbations converge on lysosomal membrane damage and vATPase dysfunction.

Shared nodes: Endosomal Nexus

Extends (25)

Ralph Nixon ↔ Pamela Maher (strong)

Maher's oxytosis/ferroptosis pathway provides the biochemical bridge to Nixon's vATPase failure: 4-HNE generated from lipid peroxidation directly poisons the lysosomal vATPase, explaining HOW the acidification failure Nixon describes is triggered by oxidative stress.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Bernd Moosmann (strong)

Moosmann provides an upstream trigger for Nixon's lysosomal failure: NMDA receptor hypofunction deprives neurons of calcium/cAMP/PKA signaling required for vATPase assembly, offering a synaptic-activity-dependent explanation for why vATPase fails in the first place.

Shared nodes: Endosomal Nexus, Compensatory Paradigm Nexus

Ralph Nixon ↔ Ari Rappoport (strong)

Rappoport's cholesterol deficiency model feeds directly into Nixon's vATPase failure: lipid raft destabilization from failed astrocyte-to-neuron cholesterol transport impairs vATPase assembly, and ApoE4 endosomal trapping creates the traffic jams Nixon describes.

Shared nodes: Endosomal Nexus, APOE4 Hub

Ralph Nixon ↔ Zhen Huang (strong)

Huang provides a neuroinflammatory route to Nixon's vATPase failure: Abeta monomer depletion disinhibits microglial TNF-alpha release, which directly inhibits neuronal vATPase, connecting immune dysregulation to autophagic collapse.

Shared nodes: Endosomal Nexus, Neuroimmune Interface

Ralph Nixon ↔ Russell Swerdlow (strong)

Swerdlow's mitochondrial cascade provides the bioenergetic explanation for Nixon's vATPase failure: ATP depletion from declining mitochondrial Complex IV activity starves the energy-dependent vATPase proton pump, causing lysosomal de-acidification.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Ruth Itzhaki (strong)

Itzhaki's HSV1 hypothesis provides a specific environmental trigger for Nixon's autophagic collapse: the virus actively sabotages autophagy-lysosomal function via ICP34.5 sequestration of Beclin-1 and vATPase trafficking disruption, creating mechanistic isomorphism with all stages of Nixon's model.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Stephen Dominy (strong)

Dominy's P. gingivalis gingipains provide another infectious route to Nixon's autophagic collapse: gingipains directly inhibit vATPase, cleave VAMP8 to block autophagosome-lysosome fusion, and suppress TFEB-mediated compensatory lysosomal biogenesis.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Paul Cox (moderate)

Cox's BMAA hypothesis provides an environmental toxin route to Nixon's lysosomal failure: BMAA exposure disrupts TRPML1 function, impairing lysosomal biogenesis and acidification, while misincorporated BMAA causes proteostatic overload that overwhelms autophagic capacity.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Zaven Khachaturian (strong)

Khachaturian's calcium hypothesis provides a systems-level upstream driver for Nixon's vATPase failure: chronic calcium dysregulation activates calpain-mediated cleavage of vATPase subunits, directly disabling the proton pump that Nixon places at the center of autophagic collapse.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Daniel Michaelson (strong)

Michaelson explains HOW ApoE4 causes Nixon's vATPase failure: ApoE4 hypolipidation starves endolysosomal membranes of lipids needed for vATPase V1/V0 domain assembly, creating a lipid-structural basis for the acidification failure Nixon describes.

Shared nodes: Endosomal Nexus, APOE4 Hub

Ralph Nixon ↔ Li-Huei Tsai (moderate)

Tsai's 40Hz gamma entrainment offers a therapeutic rescue of Nixon's autophagic collapse: bioenergetic restoration of mitochondrial ATP production re-powers vATPase function, while microglial phagocytic activation and glymphatic clearance address downstream consequences.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Brian Head (moderate)

Head's Caveolin-1 gene therapy directly addresses Nixon's vATPase failure: Cav-1 chaperoning of V1/V0 domains stabilizes the proton pump, while RELCH-mediated cholesterol clearance from lysosomal membranes restores acidification.

Shared nodes: Endosomal Nexus

Ralph Nixon ↔ Bess Frost (strong)

Frost extends Nixon's model downstream: tau-induced Moesin activation disrupts vATPase localization and lysosomal acidification, while tau-driven transposable element reactivation creates a sterile neuroinflammatory feed-forward loop that accelerates autophagic collapse.

Shared nodes: Endosomal Nexus, Transcriptional-Epigenetic Dysregulation Node

Ralph Nixon ↔ Charles Greenblatt (moderate)

Greenblatt's BCG/trained immunity hypothesis provides a therapeutic mechanism for reversing Nixon's vATPase failure: the glycolytic switch recruits Aldolase A to scaffold vATPase reassembly on lysosomal membranes, directly restoring the acidification that Nixon identifies as the critical failure point.

Shared nodes: Endosomal Nexus, Neuroimmune Interface

Ruth Itzhaki ↔ Annalise Barron (moderate)

Barron's LL-37 antimicrobial peptide defense extends Itzhaki's viral hypothesis: loss of LL-37 chaperone function (via vitamin D deficiency or pathogen degradation) removes the innate defense against both viral and bacterial triggers that Itzhaki and others identify as AD initiators.

Shared nodes: Neuroimmune Interface

Russell Swerdlow ↔ Li-Huei Tsai (moderate)

Tsai's 40Hz gamma entrainment provides a potential therapeutic for Swerdlow's mitochondrial energy failure: bioenergetic restoration of mitochondrial ATP upregulation re-powers the vATPase that fails when mitochondria decline, offering a non-pharmacological intervention.

Shared nodes: Endosomal Nexus

Estela Area-Gomez ↔ Brian Head (moderate)

Head's Caveolin-1 gene therapy directly addresses Area-Gomez's lipid raft disruption: SynCav1 restores membrane lipid raft scaffolding and RELCH-mediated cholesterol transport, correcting the lipid imbalance that Area-Gomez identifies as the root cause of vATPase failure.

Shared nodes: Endosomal Nexus

Bess Frost ↔ Maxim Shokhirev (moderate)

Frost's tau-induced transposable element reactivation and chromatin restructuring provide a molecular mechanism for the transcriptional-epigenetic dysregulation that Shokhirev's multi-omics analysis identifies as a disease hallmark, connecting tau pathology to genome-wide expression changes.

Shared nodes: Transcriptional-Epigenetic Dysregulation Node

Michal Schwartz ↔ Brenda Aske (moderate)

Aske's COIL hypothesis explains WHY Schwartz's microglial clearance fails: lipid-burdened LDAM microglia cannot phagocytose aggregates due to lysosomal acidification failure, necessitating the peripheral MDM recruitment that Schwartz proposes as the therapeutic solution.

Shared nodes: Neuroimmune Interface

Alan Snow ↔ Gunnar Gouras (moderate)

Snow's HSPG hypothesis extends Gouras's intraneuronal Abeta model: HSPGs provide the obligate scaffolding for amyloid nucleation, and lysosomal HSPG storage as indigestible substrate could explain why endolysosomal clearance fails and Abeta accumulates in the endosomal compartments Gouras identifies.

Shared nodes: Endosomal Nexus

Richelle Cutler ↔ Li-Huei Tsai (weak)

Cutler identifies viral-induced glymphatic suppression via hyperadrenergic vasoconstriction; Tsai's GENUS protocol enhances glymphatic clearance via AQP4-mediated CSF flushing. Tsai's approach may therapeutically reverse the glymphatic failure Cutler attributes to herpesvirus infection.

Shared nodes: Endosomal Nexus

Carlo Abbate ↔ Bess Frost (moderate)

Abbate's migrating neuroblasts carry hyperphosphorylated 3R-tau as pathological seeds, and Frost's work shows how tau then induces F-actin over-stabilization, nuclear envelope disruption, and transposable element reactivation. Frost provides the downstream molecular cascade for the tau seeds that Abbate's neuroblasts distribute.

Shared nodes: Cytoskeletal Collapse Node

Brian Head ↔ Daniel Michaelson (moderate)

Head's Caveolin-1 gene therapy provides a potential therapeutic for Michaelson's ApoE4 hypolipidation problem: by restoring non-vesicular cholesterol transport and lipid raft scaffolding, SynCav1 bypasses the ApoE4-mediated lipid delivery failure that Michaelson shows causes vATPase disassembly.

Shared nodes: Endosomal Nexus, APOE4 Hub

Pamela Maher ↔ Brenda Aske (weak)

Maher's 12/15-LOX-mediated lipid peroxidation generating 4-HNE provides the molecular mechanism for how Aske's lipid-burdened LDAM microglia develop lysosomal failure: 4-HNE poisoning of vATPase in glial cells would create the same acidification failure that Maher demonstrates in neurons.

Shared nodes: Endosomal Nexus

Bernd Moosmann ↔ Li-Huei Tsai (moderate)

Tsai's 40Hz gamma entrainment may rescue Moosmann's excitatory insufficiency: restoring gamma oscillations could compensate for NMDA receptor hypofunction by re-establishing the neural activity patterns needed for calcium/cAMP/PKA signaling that maintain vATPase assembly.

Shared nodes: Endosomal Nexus, Compensatory Paradigm Nexus

Supports (4)

Russell Swerdlow ↔ Maxim Shokhirev (strong)

Shokhirev's multi-omics data provides independent computational validation for Swerdlow's mitochondrial cascade: machine learning identifies proteostasis and energy metabolism as the earliest disease drivers (<75 years), with immune activation appearing later, matching Swerdlow's predicted temporal sequence.

Shared nodes: Endosomal Nexus

Zhen Huang ↔ Annalise Barron (moderate)

Barron's demonstration that LL-37 can chaperone and detoxify Abeta supports Huang's antimicrobial peptide framework: both treat Abeta as part of the innate immune system, and Barron shows that when the LL-37 defense fails, Abeta's antimicrobial aggregation becomes pathological.

Shared nodes: Neuroimmune Interface

Donald Weaver ↔ Ruth Itzhaki (moderate)

Weaver's classification of Abeta as an innate immune cytokine and antimicrobial peptide supports Itzhaki's model where Abeta is produced as an antimicrobial response to HSV1 infection. Weaver provides the immune-theoretical framework for why Abeta would be upregulated in response to the viral trigger Itzhaki identifies.

Shared nodes: Neuroimmune Interface

Maxim Shokhirev ↔ Zaven Khachaturian (moderate)

Shokhirev's data-driven temporal hierarchy validates Khachaturian's systems theory: the multi-omics identification of early proteostasis and energy metabolism failure followed by later immune activation matches Khachaturian's prediction of a nonlinear phase transition from compensated to decompensated neuronal states.

Shared nodes: Endosomal Nexus

Contradicts (3)

Bernd Moosmann ↔ Ashley Bush (moderate)

Moosmann reframes Abeta as a physiological glutamatergic sensitizer (protective at picomolar concentrations), while Bush views amyloid plaques as compensatory sinks for toxic lipid aldehydes and iron. Both see Abeta as non-causal, but disagree on its physiological function.

Shared nodes: Compensatory Paradigm Nexus

Bernd Moosmann ↔ Zhen Huang (moderate)

Both propose concentration-dependent duality for Abeta but with different functional roles. Moosmann sees monomeric Abeta as a glutamatergic sensitizer; Huang frames it as an antimicrobial peptide and synaptic competition mediator. The protective function they assign differs fundamentally.

Shared nodes: Compensatory Paradigm Nexus

Michal Schwartz ↔ Donald Weaver (strong)

Schwartz views peripheral immune cell recruitment as protective (MSR1+ MDMs clear aggregates), while Weaver's autoimmune framework implies immune attack on neurons is pathological (Abeta-mediated pore formation is a mistaken immune response). They fundamentally disagree on whether immune activation is the solution or the problem.

Shared nodes: Neuroimmune Interface

Parallel (5)

Ruth Itzhaki ↔ Stephen Dominy (strong)

Different pathogens, same downstream collapse: Itzhaki's HSV1 sabotages autophagy via Beclin-1 sequestration and vATPase disruption, while Dominy's P. gingivalis gingipains inhibit vATPase and cleave VAMP8. Both infectious triggers converge on autophagic collapse through distinct molecular mechanisms.

Shared nodes: Endosomal Nexus, Neuroimmune Interface

Ashley Bush ↔ Erwin Roggen (moderate)

Different upstream triggers but same oxidative stress convergence: Bush identifies iron accumulation driving Fenton chemistry and lipid peroxidation; Roggen identifies environmental neurotoxicants (pesticides, metals) causing mitochondrial ROS production. Both converge on oxidative stress overwhelming autophagic clearance.

Shared nodes: Endosomal Nexus

Alan Snow ↔ Carlo Abbate (weak)

Different nucleation mechanisms for plaque formation: Snow proposes HSPG/perlecan as obligate scaffold for extracellular amyloid nucleation; Abbate proposes migrating neuroblasts carrying tau seeds from neurogenesis niches. Both offer alternatives to the amyloid cascade as the template for pathological protein aggregation.

Shared nodes: Neuroimmune Interface

Richelle Cutler ↔ Stephen Dominy (moderate)

Different pathogens sabotaging the same cellular machinery: Cutler's herpesviruses use pp150/BicD1 to block Rab6-mediated retrograde transport; Dominy's P. gingivalis gingipains cleave VAMP8 to block autophagosome-lysosome fusion. Both infectious agents converge on endosomal-lysosomal dysfunction.

Shared nodes: Endosomal Nexus

Paul Cox ↔ Stephen Dominy (moderate)

Different environmental triggers converging on lysosomal failure: Cox's BMAA toxin disrupts TRPML1 and lysosomal biogenesis; Dominy's P. gingivalis gingipains inhibit vATPase and TFEB. Both propose exogenous agents that directly sabotage the lysosomal-autophagic system from different entry points.

Shared nodes: Endosomal Nexus